Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.

Authors :: Hasan S
Zorio O
Keegan BM
Weinshenker BG
Flanagan EP
Tobin WO
Kantarci OH
Toledano M
Pittock SJ
Lopez-Chiriboga S
Zekeridou A
Valencia-Sanchez C
Source :: Journal of neurology [J Neurol] 2023 Oct; Vol. 270 (10), pp. 4707-4712. Date of Electronic Publication: 2023 Aug 19.
Publication Year :: 2023

Subjects :: Humans
Immune Checkpoint Inhibitors adverse effects
Neoplasms drug therapy
Demyelinating Diseases chemically induced

Full Text Access

Tools